```html

Pre‑menstrual syndrome (PMS)

What is Pre‑menstrual syndrome (PMS)?

Pre‑menstrual syndrome (PMS) is a collection of physical, emotional, and behavioral symptoms that occur repetitively during the luteal phase of the menstrual cycle—typically 5 to 14 days after ovulation—and usually resolve with the onset of menstruation. While most women experience some mild pre‑menstrual changes, PMS is diagnosed when symptoms are severe enough to interfere with daily activities, relationships, or work.

According to the Mayo Clinic, 20‑30 % of menstruating individuals meet criteria for PMS, and about 3‑8 % develop the more intense form known as pre‑menstrual dysphoric disorder (PMDD).

Common Causes

The exact cause of PMS is not fully understood, but several physiological and lifestyle factors appear to contribute. Below are the most frequently cited contributors:

• Hormonal fluctuations – rapid changes in estrogen and progesterone after ovulation can affect neurotransmitters such as serotonin.
• Serotonin imbalance – low serotonin activity may influence mood, appetite, and sleep.
• GABA (gamma‑aminobutyric acid) alterations – GABA modulates anxiety and may be destabilized by hormonal shifts.
• Vitamin and mineral deficiencies – low calcium, magnesium, vitamin D, or B‑vitamin levels have been linked to more pronounced symptoms.
• Genetic predisposition – family history of PMS or mood disorders increases risk.
• High stress or poor coping mechanisms – chronic stress amplifies the brain’s response to hormonal changes.
• Underlying medical conditions – thyroid disease, diabetes, and irritable bowel syndrome can magnify PMS‑like symptoms.
• Unhealthy lifestyle habits – excessive caffeine, alcohol, smoking, or a diet high in refined sugars.
• Medication side‑effects – certain antidepressants, hormonal contraceptives, or antipsychotics may worsen pre‑menstrual changes.
• Gut microbiome imbalance – emerging research suggests that dysbiosis may affect estrogen metabolism and inflammation, influencing PMS severity.

Associated Symptoms

PMS manifests with a broad spectrum of symptoms. They are usually grouped into three categories: emotional/behavioral, physical, and cognitive.

Emotional & Behavioral

• Irritability or anger
• Feelings of sadness or tearfulness
• Heightened anxiety or tension
• Reduced interest in usual activities
• Changes in libido
• Sleep disturbances (insomnia or hypersomnia)

Physical

• Bloating and weight gain
• Breast tenderness
• Headaches or migraine
• Abdominal cramps
• Joint or muscle pain
• Fatigue or low energy
• Acne flare‑ups
• Gastrointestinal changes (diarrhea or constipation)

Cognitive

• Difficulty concentrating
• Memory lapses (“brain fog”)
• Reduced alertness

For a diagnosis of PMS, symptoms must appear consistently in the luteal phase, improve within a few days of menstruation, and be severe enough to cause functional impairment. When symptoms are extreme (e.g., severe depression, panic attacks, or suicidal thoughts), the condition may be classified as PMDD.

When to See a Doctor

Most women can manage mild PMS with lifestyle adjustments, but professional evaluation is warranted when any of the following occur:

• Symptoms disrupt work, school, or relationships.
• Emotional changes are intense, such as persistent sadness, hopelessness, or thoughts of self‑harm.
• Physical pain is severe (e.g., debilitating cramps, migraines, or breast pain).
• Symptoms do not improve after the onset of menstruation.
• You have a history of mood disorders, thyroid disease, or other chronic illnesses that could be contributing.
• You are considering hormonal contraception or other prescription therapies and need guidance.

Diagnosis

Diagnosing PMS is primarily clinical, relying on a thorough history and symptom pattern. The typical work‑up includes:

1. Detailed menstrual history – dates of cycle start, length, and timing of symptoms.
2. Symptom diary – a prospective log (usually 2–3 cycles) noting daily physical and emotional changes. The CDC‑endorsed Premenstrual Symptoms Screening Tool (PSST) is often used.
3. Physical examination – to rule out other conditions such as anemia, thyroid disease, or pelvic pathology.
4. Laboratory tests (when indicated) – Complete blood count, serum ferritin, TSH, fasting glucose, and possibly vitamin D or calcium levels.
5. Psychiatric screening – especially if depression, anxiety, or suicidal ideation is present; the DSM‑5 criteria for PMDD may be applied.

Imaging (ultrasound or MRI) is rarely needed unless there is suspicion of ovarian cysts, fibroids, or other structural abnormalities.

Treatment Options

Effective management combines lifestyle modifications, dietary changes, supplements, and, when necessary, pharmacologic therapy.

Lifestyle & Home Remedies

• Regular aerobic exercise – 30 minutes most days reduces fatigue and mood swings (Cleveland Clinic).
• Sleep hygiene – aim for 7–9 hours, maintain a consistent schedule.
• Stress‑reduction techniques – yoga, mindfulness meditation, or deep‑breathing exercises.
• Limit caffeine, alcohol, and nicotine – especially in the luteal phase.
• Balanced diet – emphasize complex carbs, lean protein, fruits, vegetables, and omega‑3 fatty acids (found in fish, walnuts, flaxseed).
• Hydration – adequate water intake can lessen bloating.
• Heat therapy – warm packs or baths for abdominal cramps.

Supplements

• Calcium 1,200 mg/day (shown to reduce PMS severity – Mayo Clinic).
• Magnesium 200‑400 mg/day (beneficial for mood and bloating).
• Vitamin B6 50‑100 mg/day (helps with irritability, but avoid >100 mg due to neuropathy risk).
• Vitamin D 1,000‑2,000 IU/day if deficient.
• Omega‑3 fatty acids 1 g/day (EPA/DHA) – modest improvement in depressive symptoms.

Pharmacologic Therapies

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen or naproxen for breast tenderness and cramps.
• Acetaminophen – for mild headache or pain.
• Antidepressants (SSRIs) – fluoxetine, sertraline, or paroxetine can be taken continuously or only during the luteal phase; FDA‑approved for PMDD.
• Hormonal contraceptives – combined oral contraceptives or the levonorgestrel intrauterine system may stabilize hormone fluctuations.
• Gonadotropin‑releasing hormone (GnRH) agonists – reserved for severe, refractory cases, usually combined with “add‑back” estrogen/progesterone to avoid bone loss.
• Diazepam or other short‑acting anxiolytics – may be prescribed for acute severe anxiety, but use is limited due to dependence risk.

Therapeutic Counseling

Cognitive‑behavioral therapy (CBT) has demonstrated efficacy in reducing emotional symptoms and improving coping skills. Referral to a mental‑health professional is advisable when mood disturbances dominate the clinical picture.

Prevention Tips

Although you cannot completely prevent hormonal cycles, the following strategies can lessen the frequency and intensity of PMS episodes:

• Maintain a consistent exercise routine (≥150 min moderate‑intensity/week).
• Eat a high‑fiber, low‑sugar diet rich in whole grains, legumes, and leafy greens.
• Track your cycle with a mobile app or journal to anticipate symptom onset.
• Ensure adequate intake of calcium (≥1,200 mg) and magnesium (≈350 mg).
• Consider short‑term supplementation of vitamin B6 and vitamin D after checking serum levels.
• Practice relaxation techniques daily (5‑10 min breathing exercises, progressive muscle relaxation).
• Avoid smoking and limit alcohol to ≤1 drink per day.
• Discuss with your provider the possibility of hormonal birth control that may stabilize hormone swings if you have regular menstrual cycles.

Emergency Warning Signs

---

References:

1. Mayo Clinic. “Premenstrual syndrome (PMS).” https://www.mayoclinic.org. Accessed June 2026.
2. Cleveland Clinic. “Premenstrual syndrome (PMS) and PMDD.” https://my.clevelandclinic.org. Accessed June 2026.
3. CDC. “Premenstrual Symptoms Screening Tool (PSST).” https://www.cdc.gov. Accessed June 2026.
4. National Institutes of Health (NIH). “Hormonal Contraception and Mood.” https://www.nichd.nih.gov. Accessed June 2026.
5. World Health Organization. “Guidelines for the Management of Menstrual Disorders.” WHO Press, 2022.

```